Frontlight ResearchEarly access
Childhood cancers trials in United Kingdom
158 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Enrolling by invitationAdoptive Cell Therapy Long-term Follow-up (LTFU) Study
- Where
- London, Manchester, Sutton
- People
- 250 worldwide
- Run by
- USWM CT, LLC
See details and how to joinNCT03391778 - Phase 1Taking peopleAllogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ Malignancies
- Where
- London
- Age
- 16 years to 65 years
- People
- 12
- Run by
- University College, London
See details and how to joinNCT05391490 - No phaseTaking peopleDetermining the Mechanisms of Loss of CAR T Cell Persistence
- Where
- London, Manchester
- Age
- Up to 25 years
- People
- 50
- Run by
- University College, London
See details and how to joinNCT05809284 - Phase 2Taking peopleA Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Where
- London, Manchester
- Age
- 1 year to 39 years
- People
- 105 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05999994 - Phase 1Taking peopleMulti-modular Chimeric Antigen Receptor T Cells tarGeting B7-H3 in Children, Teenage & Young Adult Sarcoma
- Where
- London
- Age
- 1 year to 24 years
- People
- 12
- Run by
- University College, London
See details and how to joinNCT07751380 - No phaseTaking peopleHER2+ CNS Surveillance
- Where
- Liverpool
- Age
- 16 years and over
- People
- 69
- Run by
- The Clatterbridge Cancer Centre NHS Foundation Trust
See details and how to joinNCT07748598 - No phaseTaking peopleIntra-operative Detection of Positive Margins and Lymph Nodes in Breast Surgery
- Where
- Nottingham
- People
- 120
- Run by
- University of Nottingham
See details and how to joinNCT06977698 - No phaseTaking peopleBeSpoke Decision Support for Patients With Newly Diagnosed Localised Prostate Cancer
- Where
- London
- People
- 346
- Run by
- University College, London
See details and how to joinNCT07135271 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- London, Manchester
- Age
- 8 years and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - Phase 3Taking peopleVO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
- Where
- Liverpool, London, Manchester
- Age
- 12 years and over
- People
- 400 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06264180 · EU 2023-508612-29-00 - Phase 1/2Taking peopleStudy of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- Where
- Birmingham, Glasgow, London, Manchester, Oxford, Preston, Southampton
- Age
- 12 years and over
- People
- 361 worldwide
- Run by
- ModernaTX, Inc.
See details and how to joinNCT05533697 · EU 2023-504506-11-00 - No phaseNot yet taking people in United KingdomA Pilot Study of the VosCryoTM Breathalyser in Lung Cancer
- Where
- Sheffield
- Age
- 16 years and over
- People
- 24
- Run by
- Sheffield Teaching Hospitals NHS Foundation Trust
See details and how to joinNCT07689968 - Phase 1/2Taking peopleEuropean Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
- Where
- Birmingham, London, Manchester, Newcastle, Sutton
- Age
- Up to 18 years
- People
- 472 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT02813135 · EU 2024-514791-40-00 - Phase 3Taking peopleBrentuximab Vedotin in Early Stage Hodgkin Lymphoma
- Where
- Aberdeen, Basingstoke, Birmingham, Blackpool, Bodelwyddan, Bristol, Cardiff, Colchester, Coventry, Glasgow, Hull, Leeds, Leicester, Liverpool, London, Manchester, Newcastle upon Tyne, Norwich, Nottingham, Oxford, Plymouth, Sheffield, Southampton, Sunderland, Sutton, Torquay, Truro
- Age
- 16 years to 69 years
- People
- 1,042 worldwide
- Run by
- University College, London
See details and how to joinNCT04685616 · EU 2022-500031-37-00 - Phase 2Taking peopleAn Experimental Study of Belzutifan Impact on Catecholamine Metabolism
- Where
- Cambridge
- People
- 12
- Run by
- Cambridge University Hospitals NHS Foundation Trust
See details and how to joinNCT07680205 - Phase 2/3Taking peopleDETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol
- Where
- Belfast, Birmingham, Bristol, Cambridge, Cardiff, Edinburgh, Glasgow, Leicester, Liverpool, London, Manchester, Metropolitan Borough of Wirral, Newcastle, Oxford, Sheffield, Southampton, Sutton
- People
- 825
- Run by
- Cancer Research UK
See details and how to joinNCT05722886 - No phaseTaking peopleSPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
- Where
- Birmingham, Bodelwyddan, Cambridge, Cardiff, Coventry, Edinburgh, Glasgow, Hereford, Leeds, Liverpool, London, Manchester
- Age
- 12 years and over
- People
- 4,975 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT02834884 - No phaseTaking peopleBlastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
- Where
- Chelmsford, Lincoln
- People
- 200 worldwide
- Run by
- Immune Oncology Research Institute
See details and how to joinNCT05430971 - Phase 2Not yet taking people in United KingdomStudy of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Where
- London
- Age
- 12 months to 39 years
- People
- 120 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05843253 - Phase 1/2CompletedA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- London, Manchester, Sutton
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - Phase 1Taking peopleCARPALL: Immunotherapy With CD19+CD22 CAR T-cells for CD19+ and CD22+ Acute Lymphoblastic Leukaemia
- Where
- London, Manchester
- Age
- Up to 24 years
- People
- 50
- Run by
- University College, London
See details and how to joinNCT02443831 - No phaseTaking peopleGenetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
- Where
- Leicester, London, Newcastle upon Tyne
- Age
- 6 years and over
- People
- 10,000
- Run by
- Barts & The London NHS Trust
See details and how to joinNCT00461188 - No phaseTaking peopleUtility of PET-MRI in Surveillance of Paediatric Brain Tumours
- Where
- Sheffield
- Age
- 8 years to 18 years
- People
- 5
- Run by
- Sheffield Children's NHS Foundation Trust
See details and how to joinNCT05553899 - No phaseTaking peopleTessa Jowell BRAIN MATRIX - Platform Study
- Where
- Birmingham, Cambridge, Cardiff, Edinburgh, Glasgow, Leeds, Liverpool, London, Manchester, Newcastle upon Tyne, Nottingham, Oxford
- Age
- 16 years and over
- People
- 1,000
- Run by
- University of Birmingham
See details and how to joinNCT04274283 - Phase 2Taking peopleMethods of T Cell Depletion Trial (MoTD)
- Where
- Birmingham, Bristol, Cambridge, Cardiff, Glasgow, Leeds, London, Manchester, Newcastle upon Tyne, Nottingham, Oxford, Plymouth, Sheffield, Sutton
- Age
- 16 years to 70 years
- People
- 400
- Run by
- University of Birmingham
See details and how to joinNCT04888741